Answer
This question has not yet been answered.
The “dark side” of semaglutide is not that it is inherently bad; it is that it can be powerful, unpleasant, long-term, and risky when used casually or through sketchy sources.
The most common downside is GI misery: nausea, diarrhea, vomiting, constipation, abdominal pain, reflux, burping, bloating, and fatigue. In adult Wegovy trials, nausea was reported in 44% of people on semaglutide 2.4 mg versus 16% on placebo; diarrhea 30% vs 16%, vomiting 24% vs 6%, and constipation 24% vs 11%. About 6.8% stopped treatment because of adverse reactions, versus 3.2% on placebo.
The more serious risks include pancreatitis, gallbladder disease, dehydration-related kidney injury, severe or persistent GI symptoms, allergic reactions, and worsening diabetic retinopathy in some people with diabetes. Semaglutide slows stomach emptying, so it is not recommended in severe gastroparesis, can affect some oral medicines, and has been linked to rare aspiration reports during anesthesia or deep sedation.
There are also rarer safety concerns. The European Medicines Agency concluded in 2025 that NAION, a rare optic-nerve condition that can cause sudden vision loss, should be listed as a very rare side effect of semaglutide medicines; sudden vision loss or rapidly worsening eyesight needs urgent medical attention. The FDA has also evaluated reports of suicidal thoughts/actions with GLP-1 drugs and said its review did not find evidence of a causal link, though it could not definitively rule out a very small risk.
Another underappreciated downside is that it may behave like a long-term maintenance drug. In the STEP 1 extension, participants regained about two-thirds of their prior weight loss one year after stopping semaglutide 2.4 mg and lifestyle intervention, with many cardiometabolic improvements moving back toward baseline. That does not mean everyone regains everything, but it means short-term use without a maintenance plan often disappoints.
There are also “wrong person / wrong source” risks. Semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2, and in people with serious hypersensitivity to the drug. It is generally avoided around pregnancy planning; Ozempic labeling says to stop at least 2 months before a planned pregnancy because of the drug’s long washout period.
The sketchiest dark side is counterfeit or compounded semaglutide. Health Canada has warned about unauthorized and counterfeit GLP-1 products and says compounding should not be used to bypass drug approval systems. The FDA has reported dosing errors with compounded injectable semaglutide, including some cases requiring medical attention or hospitalization, with adverse events such as vomiting, dehydration, pancreatitis, and gallstones.
Bottom line: semaglutide can be a legitimate, effective medication, but the “dark side” is GI side effects, rare serious complications, possible long-term dependence for weight maintenance, muscle/nutrition concerns if intake drops too much, and major safety risks from unregulated versions. It is safest when prescribed for a clear medical indication with monitoring, nutrition support, and a plan for what happens if you stop.
Do you have the same question? Follow this Question
This question has not yet been answered.